StoxDivi's Laboratories vs Dr. Reddy's Laboratories: share price & financials comparison
NSE: DIVISLAB vs DRREDDY · Healthcare · as of 13 Nov 2026
Both prices rebased to 100 at the start of the selected period.
Divi's Laboratories vs Dr. Reddy's Laboratories at a glance
Divi's Laboratories (DIVISLAB) has a market capitalisation of ₹3,03,213 Cr, against ₹1,15,230 Cr for Dr. Reddy's Laboratories (DRREDDY). Over the past year Divi's Laboratories has returned +68.2%, compared with +15.0% for Dr. Reddy's Laboratories. On valuation, Dr. Reddy's Laboratories trades at a lower P/E of 41.2 versus 90.2. Divi's Laboratories earns a higher return on equity (18.7% vs 7.2%). Divi's Laboratories comes out ahead on profitability, growth, momentum and technicals. Dr. Reddy's Laboratories comes out ahead on size and valuation. Across the scored metrics below, Divi's Laboratories leads on 11 and Dr. Reddy's Laboratories on 6. On StoxGud's 10-point checklist, Divi's Laboratories scores 8/10 and Dr. Reddy's Laboratories scores 5/10.
| Metric | Divi's Laboratories | Dr. Reddy's Laboratories |
|---|---|---|
| Size | ||
| Market cap | ₹3,03,213 Cr | ₹1,15,230 Cr |
| Revenue (latest FY) | ₹10,560 Cr | ₹33,700 Cr |
| Net profit (latest FY) | ₹2,568 Cr | ₹4,196 Cr |
| Valuation | ||
| P/E | 90.2 | 41.2 |
| P/B | 16.85 | 2.97 |
| Dividend yield | 0.26% | 0.58% |
| Profitability | ||
| Return on equity | 18.7% | 7.2% |
| Net profit margin | 27.6% | 8.5% |
| Operating margin | 38.1% | 14.7% |
| Growth | ||
| Revenue growth (YoY) | +35.4% | -1.5% |
| Net profit growth (YoY) | +63.6% | -31.3% |
| Revenue CAGR (multi-year) | +11.8% | +12.1% |
| Financial health | ||
| Debt to equity | 0.00 | 0.15 |
| Momentum | ||
| 1-month return | +23.2% | +11.3% |
| 1-year return | +68.2% | +15.0% |
| 3-year CAGR | +48.3% | +8.4% |
| 5-year CAGR | +18.5% | +7.2% |
| 10-year CAGR | +25.7% | +7.6% |
| Distance from 52W high | -1.1% | -0.5% |
| Technicals | ||
| RSI (14) | 91 | 85 |
| Price vs 200-day avg | +52.4% | +10.1% |
Highlighted cells lead on that metric. Market cap, revenue and RSI are shown for context and not scored.
10-point checklist side by side
| Check | Divi's Laboratories | Dr. Reddy's Laboratories |
|---|---|---|
| Price above 50-day average | ✓ | ✓ |
| Price above 200-day average | ✓ | ✓ |
| 50-day average above 200-day (uptrend) | ✓ | ✗ |
| RSI in healthy 40–70 zone | ✗ | ✗ |
| Positive 1-year return | ✓ | ✓ |
| Return on equity above 15% | ✓ | ✗ |
| Debt to equity below 1 | ✓ | ✓ |
| Revenue growing year on year | ✓ | ✗ |
| Net profit margin above 10% | ✓ | ✗ |
| P/E below industry median | ✗ | ✓ |
| Score | 8/10 | 5/10 |
A rules-based screen for education only — not a buy or sell recommendation.
FAQs
Which is bigger, Divi's Laboratories or Dr. Reddy's Laboratories?
Divi's Laboratories has a market cap of ₹3,03,213 Cr and Dr. Reddy's Laboratories has a market cap of ₹1,15,230 Cr as of 13 Nov 2026.
Which has a lower P/E, Divi's Laboratories or Dr. Reddy's Laboratories?
Dr. Reddy's Laboratories has the lower P/E: Divi's Laboratories trades at 90.2 and Dr. Reddy's Laboratories at 41.2.
Which gave better returns in the last year, Divi's Laboratories or Dr. Reddy's Laboratories?
Divi's Laboratories did better: Divi's Laboratories returned +68.2% and Dr. Reddy's Laboratories returned +15.0% over one year.
What is the difference between Divi's Laboratories and Dr. Reddy's Laboratories?
Both are NSE-listed companies in Healthcare. Divi's Laboratories is about 2.6 times the size of Dr. Reddy's Laboratories by market cap. In the latest financial year Divi's Laboratories reported revenue of ₹10,560 Cr and Dr. Reddy's Laboratories ₹33,700 Cr. Operating margin is 38.1% for Divi's Laboratories and 14.7% for Dr. Reddy's Laboratories. Debt to equity is 0.00 for Divi's Laboratories and 0.15 for Dr. Reddy's Laboratories.
Which is better, Divi's Laboratories or Dr. Reddy's Laboratories?
It depends on what you are looking for, and StoxGud does not recommend either stock. On the metrics compared above, Divi's Laboratories leads on 11 and Dr. Reddy's Laboratories on 6. Divi's Laboratories is ahead on profitability, growth, momentum and technicals. Dr. Reddy's Laboratories is ahead on size and valuation. On StoxGud's rules-based checklist Divi's Laboratories scores 8/10 and Dr. Reddy's Laboratories scores 5/10. This is information, not advice: consult a SEBI-registered adviser before investing.